Sign up
Pharma Capital

LeanLife issues stock options

The company said it had granted incentive stock options to certain officers, directors and consultants
omega 3
Lean Life Health develops omega-3 products which can be formulated as liquids, emulsions or powders and used as food additives

LeanLife Health Inc (CSE:LLP) said Thursday that it has granted stock options to certain officers, directors and consultants, pursuant to its 10% rolling stock option plan. 

The company said certain officers, directors and consultants will be entitled to purchase a total of 4,900,000 common shares of the company at an exercise price of C$0.05 per share for a three-year-term.

READ: LeanLife Health taps Chris Nichols as operations advisor

The company said the term will expire on February 7, 2022.

Lean Life Health develops omega-3 products which can be formulated as liquids, emulsions or powders and used as food additives

Shares of LeanLife were up 11.1% at C$0.05 on Thursday. 

View full LLP profile View Profile
View All

Related Articles

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.